Haemophilia

Cover image for Vol. 19 Issue 5

September 2013

Volume 19, Issue 5

Pages 643–798, e270–e323

  1. Commemorative Article

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. You have free access to this content
      Erik von Willebrand (pages 643–647)

      R. Lassila and O. Lindberg

      Article first published online: 25 AUG 2013 | DOI: 10.1111/hae.12243

  2. Review Articles

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
  3. Original Articles

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. Clinical haemophilia

      Establishing a harmonized haemophilia registry for countries with developing health care systems (pages 668–673)

      A. Alzoebie, M. Belhani, P. Eshghi, A. O. Kupesiz, M. Ozelo, M. T. Pompa, J. Potgieter and M. Smith

      Article first published online: 17 APR 2013 | DOI: 10.1111/hae.12147

    2. Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B (pages 674–678)

      T. Lissitchkov, M. Matysiak, K. Zavilska, P. Laguna, L. Gercheva, A. Antonov, A. Moret, P. Caunedo, J. A. Aznar, M. K. Woodward and A. Páez

      Article first published online: 7 MAY 2013 | DOI: 10.1111/hae.12148

    3. Inhibitors in haemophilia B: the Italian experience (pages 686–690)

      G. Castaman, E. Bonetti, M. Messina, M. Morfini, A. Rocino, F. A. Scaraggi, G. Tagariello and Italian Association of Hemophilia Centers

      Article first published online: 22 APR 2013 | DOI: 10.1111/hae.12158

    4. Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (pages 691–697)

      S. R. Lentz, M. Misgav, M. Ozelo, S. Z. Šalek, D. Veljkovic, M. Recht, M. Cerqueira, A. Tiede, B. Brand, M. E. Mancuso, S. Seremetis, A. Lindblom and U. Martinowitz

      Article first published online: 7 MAY 2013 | DOI: 10.1111/hae.12159

    5. Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (pages 698–705)

      R. Kulkarni, F. A. Karim, S. Glamocanin, D. Janic, V. Vdovin, M. Ozelo, L. Rageliene, E. Carboni, P. Laguna, G. Dobaczewski, S. Seremetis, A. Lindblom and E. Santagostino

      Article first published online: 8 MAY 2013 | DOI: 10.1111/hae.12165

    6. Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A (pages 706–710)

      H. Pergantou, I. Varela, O. Moraloglou, M. Economou, K. Spanou, Z. Kapsimali, N. Constantinidou and H. Platokouki

      Article first published online: 22 APR 2013 | DOI: 10.1111/hae.12168

    7. Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A (pages 720–726)

      D. Nance, S. N. Fletcher, D. C. Bolgiano, A. R. Thompson, N. C. Josephson and B. A. Konkle

      Article first published online: 28 MAY 2013 | DOI: 10.1111/hae.12173

    8. Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study (pages 727–735)

      M. J. Manco-Johnson, J. Sanders, N. Ewing, N. Rodriguez, M. Tarantino, T. Humphries and TEEN/TWEN Study Group

      Article first published online: 11 JUN 2013 | DOI: 10.1111/hae.12177

    9. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study (pages 736–743)

      A. Gringeri, C. Leissinger, P. A. Cortesi, H. Jo, F. Fusco, S. Riva, B. Antmen, E. Berntorp, C. Biasoli, S. Carpenter, K. Kavakli, M. Morfini, C. Négrier, A. Rocino, W. Schramm, J. Windyga, B. Zülfikar and L. G. Mantovani

      Article first published online: 3 JUN 2013 | DOI: 10.1111/hae.12178

    10. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters (pages 744–752)

      A. Tuinenburg, S. Biere-Rafi, M. Peters, P. Verhamme, K. Peerlinck, M. J. H. A. Kruip, B. A. P. Laros-Van Gorkom, M. Roest, J. C. M. Meijers, P. W. Kamphuisen and R. E. G. Schutgens

      Article first published online: 10 MAY 2013 | DOI: 10.1111/hae.12182

    11. von Willebrand factor

    12. Rare bleeding disorders

      Use of global assays to understand clinical phenotype in congenital factor VII deficiency (pages 765–772)

      L. A. Greene, N. A. Goldenberg, M. L. Simpson, E. Villalobos-Menuey, C. Bombardier, S. S. Acharya, P. J. Santiago-Borrero, A. Cambara and D. M. DiMichele

      Article first published online: 20 MAY 2013 | DOI: 10.1111/hae.12160

    13. Genetics

      Detection of new mutations and molecular pathology of mild and moderate haemophilia A patients from southern Brazil (pages 773–781)

      C. Rosset, I. A. Vieira, M. Sinigaglia, R. P. Gorziza, F. M. Salzano and E. Bandinelli

      Article first published online: 28 MAY 2013 | DOI: 10.1111/hae.12172

    14. Laboratory issues

    15. Musculoskeletal

      Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients (pages 790–798)

      A. Ceponis, I. Wong-Sefidan, C. S. Glass and A. von Drygalski

      Article first published online: 15 MAY 2013 | DOI: 10.1111/hae.12175

    16. Quality of life

      Impact of personality and depression on quality of life in patients with severe haemophilia in Korea (pages e270–e275)

      S.-Y. Kim, S.-W. Kim, J.-M. Kim, I.-S. Shin, H.-J. Baek, H.-S. Lee, T.-J. Hwang and J.-S. Yoon

      Article first published online: 28 JUN 2013 | DOI: 10.1111/hae.12221

    17. Women with inherited bleeding disorders

    18. Clinical haemophilia

    19. A survey of patients with haemophilia to understand how they track product used at home (pages e289–e295)

      N. S. Sholapur, R. Barty, G. Wang, T. Almonte and N. M. Heddle

      Article first published online: 15 MAY 2013 | DOI: 10.1111/hae.12170

  4. Letters to the editors

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. Two novel mutations in the prothrombin gene identified in a patient with compound heterozygous type 1/2 prothrombin deficiency (pages e304–e306)

      P. H. M. Kuijper, M. W. M. Schellings, D. van de Kerkhof, G. A. F. Nicolaes, P. Reitsma, F. Halbertsma and N. Dors

      Article first published online: 28 MAY 2013 | DOI: 10.1111/hae.12180

    2. Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity (pages e308–e310)

      P. Anagnostis, S. Vakalopoulou, M. Charizopoulou, S. Karras and V. Garipidou

      Article first published online: 28 MAY 2013 | DOI: 10.1111/hae.12187

    3. Are the standard definitions of osteopenia and osteoporosis appropriate for coinfected patients with haemophilia? (pages e316–e318)

      S. Linari, G. Montorzi, M. Borderi, D. Bartolozzi, D. Melchiorre and M. Morfini

      Article first published online: 18 JUN 2013 | DOI: 10.1111/hae.12207

    4. Quality of life in paediatric haemophilia A patients (pages e320–e323)

      V. K. Williams, G. Antoniou, A. Jackson and A. Atkins

      Article first published online: 28 JUN 2013 | DOI: 10.1111/hae.12226

SEARCH

SEARCH BY CITATION